Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
Olivier VandhuickMarianne PayetEmmanuelle PréaudJoannie Lortet-TieulentFanny RaguideauOlivier ChevreuilBenoit van HilleArnaud KwiatkowskiPublished in: Expert review of pharmacoeconomics & outcomes research (2021)
The cost of health care sick leaves, and disability pensions of HA-RRMS patients was about twice as high as previously reported cost of MS patients.